Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices
  • Print
  • Share
  • E-mail
-

GRN No. 1275

6'-Sialyllactose sodium salt

Intended Use: Intended for use as an ingredient in non-exempt infant formula for term infants and formula for young children (>12 months) at a maximum level of 0.40 g/L and 0.5 g/L (as consumed), respectively, and in other food categories at maximum levels up to 125 g/L.
Basis: Scientific procedures
Notifier: Cataya Bio (Shanghai) Co., Ltd.
Notifier Address: 4th Floor of Building No. 2
No. 88 Darwin Road
Pudong New District
Shanghai 201203
CHINA
GRAS Notice (releasable information): GRN 1275 (in PDF) (4.7 MB)
  Part 2: GRN 1275 amendments (in PDF) (1.5 MB)
Date of closure: Mar 20, 2026
FDA's Letter: FDA has no questions (in PDF) (277 kB)
-
-